References
- Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol. 2010;28:100–108.
- Bagan-Sebastian JV, Milian-Masanet MA, Penarrocha-Diago M, et al. A clinical study of 205 patients with oral lichen planus. J Oral Maxillofac Surg. 1992;50:116–118.
- Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol. 1968;25:31–42.
- Chaudhary S. Psychosocial stressors in oral lichen planus. Aust Dent J. 2004;49:192–195.
- Rojo-Moreno JL, Bagan JV, Rojo-Moreno J, et al. Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:687–691.
- Girardi C, Luz C, Cherubini K, et al. Salivary cortisol and dehydroepiandrosterone (DHEA) levels, psychological factors in patients with oral lichen planus. Arch Oral Biol. 2011;56:864–868.
- Hirota SK, Moreno RA, Dos Santos CH, et al. DA Psychological profile (anxiety and depression) in patients with oral lichen planus: a controlled study. Minerva Stomatol. 2013;62:51–56.
- Adamo D, Cascone M, Celentano A, et al. Psychological profiles in patients with symptomatic reticular forms of oral lichen planus: a prospective cohort study. J Oral Pathol Med. 2017;46:810–816.
- Gupta S, Ghosh S. Interventions for the management of oral lichen planus: a review of the conventional and novel therapies. Oral Dis. 2017;23:1029–1042.
- Van Der Meij EH, Van Der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med. 2003;32:507–512.
- Hawker GA, Mian S, Kendzerska T, et al. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res.). 2011;63 (Suppl 11):S240–S252.
- Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55.
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
- Caraceni A, Mendoza TR, Mencaglia E, et al. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996;65:87–92.
- [cited 2017 Oct 16]. Available from: http://elearning.unimib.it/pluginfile.php/238410/mod_resource/content/1/hamiltonansia.pdf
- [cited 2017 Oct 16]. Available from: http://elearning.unimib.it/pluginfile.php/238372/mod_resource/content/1/Hamilton.pdf
- Kuzel RJ. Treating comorbid depression and anxiety. J Fam Pract. 1996;43:S45–S53.
- Marken PA, Munro JS. Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features. Prim Care Companion J Clin Psychiatry. 2000;2: 205–210.
- De Moraes M, Do Amaral Bezerra BA, Da Rocha Neto PC, et al. A randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature. J Oral Pathol Med. 2012;41:281–287.
- Guarneri F, Guarneri C, Marini H. Oral lichen planus and neurogenic inflammation: new observations and therapeutic implications from four clinical cases. Dermatol Ther. 2014;27:206–210.
- O'brien EM, Waxenberg LB, Atchison JW, et al. Negative mood mediates the effect of poor sleep on pain among chronic pain patients. Clin J Pain. 2010;26:310–319.
- Jakubovski E, Varigonda AL, Freemantle N, et al. Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder. AJP. 2016;173:174–183.
- Hasnain M, Vieweg WV. Weight considerations in psychotropic drug prescribing and switching. Postgrad Med. 2013;125:117–129.
- Blier P, Gobbi G, Turcotte JE, et al. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. Eur Neuropsychopharmacol. 2009;19:457–465.
- Jackson KC, 2nd, St Onge EL. Antidepressant pharmacotherapy: considerations for the pain clinician. Pain Pract. 2003;3:135–143.
- Adamo D, Ruoppo E, Leuci S, et al. Sleep disturbances, anxiety and depression in patients with oral lichen planus: a case-control study. J Eur Acad Dermatol Venereol. 2015;29:291–297.
- Park SJ, Yoon DM, Yoon KB, et al. Factors associated with higher reported pain levels in patients with chronic musculoskeletal pain: a cross-sectional, correlational analysis. PLoS One. 2016;11:e0163132.
- Power JD, Perruccio AV, Badley EM. Pain as a mediator of sleep problems in arthritis and other chronic conditions. Arthritis Rheum. 2005;53:911–919.
- Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011;130:226–238.
- Jaremka LM, Lindgren ME, Kiecolt-Glaser JK. Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology. Depress Anxiety. 2013;30:288–296.